316 related articles for article (PubMed ID: 23847277)
21. Rapid T cell repopulation after rabbit anti-thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus.
Havenith SH; Remmerswaal EB; Bemelman FJ; Yong SL; van Donselaar-van der Pant KA; van Lier RA; Ten Berge IJ
Clin Exp Immunol; 2012 Sep; 169(3):292-301. PubMed ID: 22861369
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system?
Wong G; Chakera A; Chapman JR; Chadban SC; Pilmore H; Craig JC; Lim WH
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27860123
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
[TBL] [Abstract][Full Text] [Related]
24. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.
Komatsu H; Kogawa K; Nonoyama S; Inui A; Sogo T; Fujisawa T; Klenerman P
J Med Virol; 2006 Dec; 78(12):1616-23. PubMed ID: 17063516
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
Fleming T; Dunne J; Crowley B
J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
[TBL] [Abstract][Full Text] [Related]
27. Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation.
Aldridge RW; Mattes FM; Rolando N; Rolles K; Smith C; Shirling G; Atkinson C; Burroughs AK; Milne RS; Emery VC; Griffiths PD
Transpl Infect Dis; 2015 Feb; 17(1):25-32. PubMed ID: 25572799
[TBL] [Abstract][Full Text] [Related]
28. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
Cummins NW; Deziel PJ; Abraham RS; Razonable RR
Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
[TBL] [Abstract][Full Text] [Related]
29. Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation.
Gandhi MK; Wills MR; Okecha G; Day EK; Hicks R; Marcus RE; Sissons JG; Carmichael AJ
Blood; 2003 Nov; 102(9):3427-38. PubMed ID: 12869514
[TBL] [Abstract][Full Text] [Related]
30. CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity.
van der Heiden PLJ; van Egmond HM; Veld SAJ; van de Meent M; Eefting M; de Wreede LC; Halkes CJM; Falkenburg JHF; Marijt WAF; Jedema I
Transpl Immunol; 2018 Aug; 49():54-58. PubMed ID: 29679650
[TBL] [Abstract][Full Text] [Related]
31. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation.
Smiley ML; Wlodaver CG; Grossman RA; Barker CF; Perloff LJ; Tustin NB; Starr SE; Plotkin SA; Friedman HM
Transplantation; 1985 Aug; 40(2):157-61. PubMed ID: 2992130
[TBL] [Abstract][Full Text] [Related]
32. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
[TBL] [Abstract][Full Text] [Related]
33. Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs.
Schlott F; Steubl D; Hoffmann D; Matevossian E; Lutz J; Heemann U; Hösel V; Busch DH; Renders L; Neuenhahn M
PLoS One; 2017; 12(1):e0171035. PubMed ID: 28129395
[TBL] [Abstract][Full Text] [Related]
34. Pre-Transplant Frequencies of FoxP3
Mooslechner AA; Schuller M; Pfeifer V; Klötzer KA; Prietl B; Kirsch AH; Stiegler P; Sucher R; Sourij H; Rosenkranz AR; Eller K
Transpl Int; 2024; 37():12963. PubMed ID: 38868358
[TBL] [Abstract][Full Text] [Related]
35. Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.
Rittà M; Costa C; Sidoti F; Ballocco C; Ranghino A; Messina M; Biancone L; Cavallo R
New Microbiol; 2015 Jul; 38(3):329-35. PubMed ID: 26147141
[TBL] [Abstract][Full Text] [Related]
36. CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant.
Yeh AC; Varelias A; Reddy A; Barone SM; Olver SD; Chilson K; Onstad LE; Ensbey KS; Henden AS; Samson L; Jaeger CA; Bi T; Dahlman KB; Kim TK; Zhang P; Degli-Esposti MA; Newell EW; Jagasia MH; Irish JM; Lee SJ; Hill GR
Blood; 2021 Dec; 138(26):2874-2885. PubMed ID: 34115118
[TBL] [Abstract][Full Text] [Related]
37. CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation.
Shi XL; de Mare-Bredemeijer EL; Tapirdamaz Ö; Hansen BE; van Gent R; van Campenhout MJ; Mancham S; Litjens NH; Betjes MG; van der Eijk AA; Xia Q; van der Laan LJ; de Jonge J; Metselaar HJ; Kwekkeboom J
Am J Transplant; 2015 Sep; 15(9):2431-42. PubMed ID: 25943855
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants.
Reusser P; Attenhofer R; Hebart H; Helg C; Chapuis B; Einsele H
Blood; 1997 May; 89(10):3873-9. PubMed ID: 9160696
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
[TBL] [Abstract][Full Text] [Related]
40. CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status.
Sellar RS; Vargas FA; Henry JY; Verfuerth S; Charrot S; Beaton B; Chakraverty R; Quezada SA; Mackinnon S; Thomson KJ; Peggs KS
Blood; 2015 Jan; 125(4):731-9. PubMed ID: 25499763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
